In the current study, doxorubicin was observed to significantly reduce expression of E-cadherin and upregulate Vimentin in HCC cells, whereas salinomycin reversed doxorubicin-induced expression changes of EMT-markers, indicating salinomycin as an EMT suppressor. The gene discussed is CDH1; the disease is hepatocellular carcinoma.